This may also precede and possibly act independent of the anti-tumor potential of Ndst1 deficient DCs that appear to boost acquired cytotoxic CD8+ T cell responses against growing macroscopic carcinomas [1]. The gene discussed is CD8A; the disease is carcinoma.